Lixiana(D006)
Sponsors
Chong Kun Dang Pharmaceutical
Conditions
Anticoagulant
Phase 1
A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344
NCT04673695
Start: 2020-11-13End: 2021-01-02Target: 50Updated: 2020-12-17
A Clinical Study to Evaluate the Safety and Pharmacokinetics of CKD-344 in Healthy Volunteers
NCT04867200
Start: 2021-04-27End: 2021-06-01Target: 60Updated: 2021-04-30